Adamis Pharmaceuticals (ADMP) has had the highest return since May 1, 2023 by a micro-cap US stock, returning 4,221%.

Adamis Pharmaceuticals (ADMP) has had the highest return since May 1, 2023 by a micro-cap US stock, returning 4,221%.
ASSET | % RETURN |
---|---|
Adamis Pharmaceuticals (ADMP) | 4,220.99% |
Galmed Pharmaceuticals (GLMD) | 1,518.12% |
Nisun International Enterprise Development (NISN) | 751.92% |
GSI Technology (GSIT) | 289.61% |
Corvus Pharmaceuticals (CRVS) | 190% |
BurgerFi International, LLC (BFIIW) | 161.94% |
ADS-TEC Energy (ADSE) | 161.3% |
Minim (MINM) | 152.88% |
Goldenbridge Acquisition (GBRGW) | 150% |
Nanobiotix (NBTX) | 128.6% |
IN8bio (INAB) | 125% |
Digital Brands (DBGIW) | 122.09% |
Minerva Neurosciences (NERV) | 115.76% |
Bellicum Pharmaceuticals (BLCM) | 113.24% |
ClearOne (CLRO) | 99.22% |
Whole Earth Brands (FREEW) | 98.71% |
Oramed Pharmaceuticals (ORMP) | 93.91% |
Bioventus (BVS) | 93.07% |
Enveric Biosciences (ENVB) | 92.39% |
Fujian Blue Hat Interactive Entertainment Technology (BHAT) | 83.57% |
Apyx Medical (APYX) | 81.98% |
Ideanomics (IDEX) | 79.69% |
NantHealth (NH) | 78.52% |
VivoPower International (VVPR) | 76.87% |
Trinity Place (TPHS) | 76.42% |
Micro-cap stocks are treated as having a market cap of <= $300M.